|
C12ORF26 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.45660000014669E-08 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.473600E-02 |
| Normal-vs-Stage2 |
8.560800E-04 |
| Normal-vs-Stage3 |
8.7957419125928E-12 |
| Normal-vs-Stage4 |
2.16171525124764E-12 |
| Stage1-vs-Stage2 |
2.370100E-02 |
| Stage1-vs-Stage3 |
1.17419999945412E-07 |
| Stage1-vs-Stage4 |
7.50219997236456E-10 |
| Stage2-vs-Stage3 |
1.903040E-01 |
| Stage2-vs-Stage4 |
6.206100E-02 |
| Stage3-vs-Stage4 |
4.080200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.37450000270434E-08 |
| Normal-vs-AfricanAmerican |
3.754500E-02 |
| Normal-vs-Asian |
7.691800E-01 |
| Caucasian-vs-AfricanAmerican |
2.659200E-01 |
| Caucasian-vs-Asian |
2.396600E-01 |
| AfricanAmerican-vs-Asian |
5.590400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.32309996292435E-09 |
| Normal-vs-Female |
1.915640E-03 |
| Male-vs-Female |
6.943900E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.095930E-02 |
| Normal-vs-Age(41-60Yrs) |
1.210150E-04 |
| Normal-vs-Age(61-80Yrs) |
1.55529999990023E-08 |
| Normal-vs-Age(81-100Yrs) |
3.638700E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.870400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.873800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.850400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.115580E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.823990E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.798200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.047600E-02 |
| Normal-vs-Grade 2 |
1.329190E-01 |
| Normal-vs-Grade 3 |
4.46531700504238E-12 |
| Normal-vs-Grade 4 |
1.62447832963153E-12 |
| Grade 1-vs-Grade 2 |
3.524400E-02 |
| Grade 1-vs-Grade 3 |
2.412499999771E-07 |
| Grade 1-vs-Grade 4 |
4.79379869133822E-11 |
| Grade 2-vs-Grade 3 |
2.28340002461636E-09 |
| Grade 2-vs-Grade 4 |
1.62458935193399E-12 |
| Grade 3-vs-Grade 4 |
2.02349999999241E-05 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.539800E-01 |
| Normal-vs-ccB subtype |
3.05311331771918E-14 |
| ccA subtype-vs-ccB subtype |
8.91953177983851E-13 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.77039999999162E-07 |
| Normal-vs-N1 |
1.05240000003448E-06 |
| N0-vs-N1 |
8.994300E-02 |
|
|
